Media Highlights
Crinetics Announces Positive Topline Results from Phase 2 Trial of Paltusotine for the Treatment of Carcinoid Syndrome
March 12, 2024
Dr. Aman Chauhan, as an investigator in the study, is quoted discussing the “clinical improvements that paltusotine demonstrated for patients with carcinoid syndrome” and the hope that this treatment might bring for those with neuroendocrine tumors.
Tags: Aman Chauhan, Neuroendocrine, Sylvester Comprehensive Cancer Center
